Article
MiR-23c Regulates the Resistance to Gefitinib in EGFR Mutant Non-Small-Cell Lung Cancer Cells.
Cells - 6 Jun 2026
Ignoto Brigitta, Parisi Ilaria Assunta, Roma Cristin, Camerlingo Rosa, Dotolo Serena, Tufano Salvatore, Maiello Monica Rosaria, Normanno Nicola, Morabito Alessandro, De Luca Antonella, Frezzetti Daniela
Abstract excerpt
Mechanisms of primary and acquired resistance are responsible for treatment failure with the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) in the majority of patients with advanced Non-Small-Cell Lung Cancer (NSCLC) carrying EGFR-activating mutations. MicroRNAs (miRNAs) are important modulators of EGFR signaling in lung cancer. Recent studies suggested the role of miR-23c as a tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
